
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
130.5866
0.0188 EUR
−30.16 M EUR
106.10 M EUR
90.67 M
About Organigram Global Inc.
Sector
Industry
CEO
Beena G. Goldenberg
Website
Headquarters
Toronto
Founded
2010
ISIN
CA68617J1003
FIGI
BBG0071MY0K4
Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 0OG is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Organigram Global Inc. stocks are traded under the ticker 0OG.
We've gathered analysts' opinions on Organigram Global Inc. future price: according to them, 0OG price has a max estimate of 2.23 EUR and a min estimate of 1.49 EUR. Watch 0OG chart and read a more detailed Organigram Global Inc. stock forecast: see what analysts think of Organigram Global Inc. and suggest that you do with its stocks.
Yes, you can track Organigram Global Inc. financials in yearly and quarterly reports right on TradingView.
Organigram Global Inc. is going to release the next earnings report on Dec 2, 2025. Keep track of upcoming events with our Earnings Calendar.
0OG earnings for the last quarter are −0.03 EUR per share, whereas the estimation was −0.01 EUR resulting in a −358.72% surprise. The estimated earnings for the next quarter are 0.00 EUR per share. See more details about Organigram Global Inc. earnings.
Organigram Global Inc. revenue for the last quarter amounts to 44.14 M EUR, despite the estimated figure of 42.43 M EUR. In the next quarter, revenue is expected to reach 44.90 M EUR.
0OG net income for the last quarter is −3.92 M EUR, while the quarter before that showed 27.27 M EUR of net income which accounts for −114.39% change. Track more Organigram Global Inc. financial stats to get the full picture.
No, 0OG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 26, 2025, the company has 898 employees. See our rating of the largest employees — is Organigram Global Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Organigram Global Inc. EBITDA is −39.08 M EUR, and current EBITDA margin is −46.76%. See more stats in Organigram Global Inc. financial statements.
Like other stocks, 0OG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Organigram Global Inc. stock right from TradingView charts — choose your broker and connect to your account.